{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:42:10Z","timestamp":1792057330888,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/j.1365-2133.2008.08992.x","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T02:46:01Z","timestamp":1229568361000},"page":"815-822","source":"Crossref","is-referenced-by-count":97,"title":["Quality of life and psychological distress in patients with cutaneous lymphoma"],"prefix":"10.1093","volume":"160","author":[{"given":"F.","family":"Sampogna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Frontani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Baliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Alvetreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tabolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Abeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2003.05698.x","article-title":"Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas","volume":"149","author":"Whittaker","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.141.3.325","article-title":"Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma","volume":"141","author":"Demierre","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB4","first-page":"91","volume-title":"Decision Making in Oncology. Evidence-based Management","author":"Djulbegovic","year":"1997"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB5","first-page":"7","article-title":"Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective","volume":"20","author":"Beitz","year":"1996","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.1996.14.2.671","article-title":"Outcomes of cancer treatment for technology assessment and cancer treatment guidelines","volume":"14","author":"American Society of Clinical Oncology","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6600001","article-title":"Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology","volume":"86","author":"Velikova","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.0022-202X.2003.09101.x","article-title":"Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis","volume":"122","author":"Sampogna","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2005.07071.x","article-title":"Measuring quality of life of patients with different clinical types of psoriasis using the SF-36","volume":"154","author":"Sampogna","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB12","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bmj.325.7372.1066","article-title":"Influence of psychological coping on survival and recurrence in people with cancer: systematic review","volume":"325","author":"Petticrew","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB13","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0889-8588(03)00111-4","article-title":"Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma","volume":"17","author":"Demierre","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2008.08992.x-BIB14","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3816\/CLM.2000.s.004","article-title":"Cutaneous T-cell lymphomas: prognosis and quality-of-life issues","volume":"1","author":"Dummer","year":"2000","journal-title":"Clin Lymphoma"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB15","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.22252","article-title":"Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey","volume":"107","author":"Demierre","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB16","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB17","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3816\/CLM.2002.n.003","article-title":"Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (Ontak\u00ae)","volume":"2","author":"Duvic","year":"2002","journal-title":"Clin Lymphoma"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.143.5.659","article-title":"Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis","volume":"143","author":"Demierre","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2133.2005.06755.x","article-title":"Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides","volume":"153","author":"Abeni","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/1523-1747.ep12285650","article-title":"Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease","volume":"108","author":"Chren","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000051809","article-title":"Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients","volume":"204","author":"Abeni","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB26","volume-title":"EORTC Quality of Life Group Translation Procedure","author":"Cull","year":"2002"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/A:1008264412398","article-title":"Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients","volume":"9","author":"Apolone","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB28","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1998.16.3.1188","article-title":"Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer core quality-of-life questionnaire: the QLQ-C30 (+ 3)","volume":"16","author":"Hjermstad","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1468-3083.2001.00336.x","article-title":"Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12","volume":"15","author":"Picardi","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB30","volume-title":"The Detection of Psychiatric Illness by Questionnaire","author":"Goldberg","year":"1972"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.psy.0000132869.96872.b2","article-title":"Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions","volume":"66","author":"Sampogna","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB32","volume-title":"SPSS for Windows: Professional and Advanced Statistics","author":"Norusis","year":"1999"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.psy.0000116775.98593.f4","article-title":"Gender differences in quality of life among cardiac patients","volume":"66","author":"Emery","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00006842-200007000-00010","article-title":"Race and sex differences in cutaneous pain perception","volume":"62","author":"Sheffield","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2133.2005.06909.x","article-title":"Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis","volume":"154","author":"Sampogna","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cpr.2004.01.002","article-title":"Psychological factors and cancer development: evidence after 30\u2003years of research","volume":"24","author":"Garssen","year":"2004","journal-title":"Clin Psychol Rev"},{"key":"10.1111\/j.1365-2133.2008.08992.x-BIB37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11920-005-0042-3","article-title":"Neurobehavioral effects of interferon therapy","volume":"7","author":"Valentine","year":"2005","journal-title":"Curr Psychiatry Rep"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08992.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:43:55Z","timestamp":1676382235000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/4\/815\/6641868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08992.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}